Revolutionary next-generation objectives launched

As a leader in optics for 100 years, Olympus has broken down barriers to imaging quality with the launch of its next-generation objectives. The breakthrough polishing technique enables the company to produce ultrathin lenses that overcome the traditional trade-off between numerical aperture (NA), flatness and chromatic correction – enabling all three parameters to be significantly improved.

Olympus has harnessed this proprietary technology to deliver high-performance X Line objectives for clinical and research applications as well as UPLAPO-HR objectives, the world’s first plan-corrected apochromat objectives with a NA of 1.5 for total internal reflection fluorescence (TIRF) microscopy and super resolution applications. The new objectives will deliver significant improvements to a plethora of research and clinical applications without the need to change or upgrade imaging systems.

Users of high-end and low-end microscopy systems can easily boost the image quality of their microscopy system by switching to X Line. Ensuring broad compatibility with different systems, X Line objectives provide these benefits without changing the mount or parfocalising distance, making it easy to upgrade this easily overlooked part of a microscope.

www.olympus-lifescience.com/en/landing/objectives

 

Other news

Learning from history

Upcoming Events

Lab Innovations

NEC, Birmingham (Hall 12)
30-31 October 2019

British Society for Immunology Congress

Arena and Convention Centre, Kings Dock, Liverpool Waterfront, Liverpool L3 4FP
2-5 December 2019

The genomic and molecular revolution in microbiology: in technology we trust (or do we?).

RAF Museum, Hendon, London
14 May 2020

Clinical and Laboratory Haemostasis 2020

STEM/Atrium Conference Centre, Sheffield Hallam University
3-4 June 2020

Latest Issue

Pathology In Practice

Pathology In Practice

Oct 2019

Are you ready for the winter influenza season?

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.